Wang Jisheng, Han Liang, Bao Binghao, Yu Xudong, Zhang Kaige, Dai Hengheng, Li Xiao, Wang Bin, Li Haisong
Graduate School of Beijing University of Chinese Medicine.
Department of Andrology, Dongzhimen Hospital.
Medicine (Baltimore). 2019 Jan;98(1):e13934. doi: 10.1097/MD.0000000000013934.
Epididymitis is a common disease in non-specific infections of the male reproductive system. According to the clinical incidence of acute epididymitis and chronic epididymitis, which is more common in chronic epididymitis. There are many clinical trials confirmed that acupuncture treatment can relieve pain and improve symptoms of epididymitis to some extent. In this systematic review, we aim to evaluate the effectiveness and safety of acupuncture for epididymitis.
We will search for PubMed, Cochrane Library, AMED, EMbase, WorldSciNet; Nature, Science online and China Journal Full-text Database (CNKI), China Biomedical Literature CD-ROM Database (CBM), and related randomized controlled trials included in the China Resources Database. The time is limited from the construction of the library to November 2018. We will use the criteria provided by Cochrane 5.1.0 for quality assessment and risk assessment of the included studies, and use the Revman 5.3 and Stata13.0 software for meta-analysis of the effectiveness, recurrence rate, and symptom scores of epididymitis.
This systematic review will evaluate the efficacy and safety of acupuncture for epididymitis. Because all of the data used in this systematic review and meta-analysis has been published, this review does not require ethical approval. Furthermore, all data will be analyzed anonymously during the review process trial.
PROSPERO CRD42018111348.
附睾炎是男性生殖系统非特异性感染中的常见疾病。根据急性附睾炎和慢性附睾炎的临床发病率,慢性附睾炎更为常见。有许多临床试验证实,针刺治疗在一定程度上可缓解附睾炎疼痛并改善症状。在本系统评价中,我们旨在评估针刺治疗附睾炎的有效性和安全性。
我们将检索PubMed、Cochrane图书馆、AMED、EMbase、WorldSciNet、《自然》《科学》在线以及中国期刊全文数据库(CNKI)、中国生物医学文献光盘数据库(CBM)以及华润数据库中纳入的相关随机对照试验。检索时间范围为各数据库建库至2018年11月。我们将使用Cochrane 5.1.0提供的标准对纳入研究进行质量评估和风险评估,并使用Revman 5.3和Stata13.0软件对附睾炎的有效性、复发率及症状评分进行Meta分析。
本系统评价将评估针刺治疗附睾炎的疗效和安全性。由于本系统评价和Meta分析中使用的所有数据均已发表,因此本评价无需伦理批准。此外,在评价过程中所有数据将进行匿名分析。
PROSPERO CRD42018111348。